President Biden will announce Monday that the United States will export 20 million doses of the Pfizer-BioNTech, Moderna, and Johnson & Johnson COVID-19 vaccines by the end of June, Bloomberg reports. Those doses are on top of the 60 million doses of the vaccine developed by the University of Oxford and AstraZeneca already earmarked for export.
The AstraZeneca vaccine has not received authorization from the Food and Drug Administration, so the U.S. wouldn’t be able to distribute the doses produced in the country anyway, but the latest development is significant because the other companies’ shots are in use domestically.
An anonymous Biden administration official told Bloomberg the measure is only a first step, and, as the vaccination rate plateaus in the U.S., the White House will increasingly turn its attention to helping curb the coronavirus pandemic abroad. The pivot comes as the global discrepancy in vaccinations has become more glaring — many lower-income countries are struggling to secure supplies even as the virus surges in many pockets of the world.
It’s not yet clear where exactly the exported vaccines will go, or how the U.S. will decide which countries get them, but White House Press Secretary Jen Psaki said the criteria should become available soon. Read more at Bloomberg.